Patents by Inventor Matthew Knight

Matthew Knight has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250122488
    Abstract: The present disclosure provides engineered adenylate kinases, and recombinant polynucleotides encoding the engineered adenylate kinases. The present disclosure further provides uses of the engineered adenylate kinases for converting NMP to NDP.
    Type: Application
    Filed: October 11, 2024
    Publication date: April 17, 2025
    Inventors: Stephanie Marie Forget, Anders Matthew Knight, Marissa Greene MacAvoy, Simon Ng, Nicholas Porter, Jonathan Vroom
  • Patent number: 12152486
    Abstract: A method for remotely signalling a downhole assembly comprising one or more downhole tools includes operating a choke arrangement configured to control production fluid flow from a wellbore to produce a first pressure signature in the fluid flow, the first pressure signature defining a trigger signal for the one or more downhole tools of the downhole assembly. The first pressure signature comprises at least a first pressure signal and a second pressure signal in the production fluid flow in the downhole assembly. Operating the choke arrangement to produce a second pressure signature in the production fluid flow in the downhole assembly at a predetermined time period following the first pressure signature, the second pressure signature defining a command signal for initiating operation of a predetermined one or more of the downhole tools of the downhole assembly.
    Type: Grant
    Filed: September 14, 2021
    Date of Patent: November 26, 2024
    Assignee: Weatherford U.K. Limited
    Inventors: Euan Murdoch, Matthew Knight, Richard Dalzell
  • Publication number: 20240376449
    Abstract: The present disclosure relates to engineered RNA polymerase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered RNA polymerase polypeptides. The present disclosure also provides methods of using the engineered RNA polymerase polypeptides or compositions thereof for producing RNA.
    Type: Application
    Filed: May 10, 2024
    Publication date: November 14, 2024
    Inventors: Marina Mikhailovna Bakhtina, Rachelle Copeland, Aldo Duran, Anders Matthew Knight, Melissa Ann Mayo
  • Publication number: 20240318152
    Abstract: The present invention provides improved P450-BM3 variants with improved activity. In some embodiments, the P450-BM3 variants exhibit improved activity on a 1-tert-Butoxycarbonylaminocyclopentanoic acid substrate.
    Type: Application
    Filed: November 21, 2023
    Publication date: September 26, 2024
    Inventors: David Entwistle, Jason Fell, Stephan Jenne, Anders Matthew Knight, Simon Ng, Ryan D. Reeves, Zara Maxine Seibel, Jonathan Vroom
  • Publication number: 20240309353
    Abstract: The present disclosure relates to engineered DNA ligase polypeptides and compositions thereof, as well as polynucleotides encoding the engineered DNA ligase polypeptides. The present disclosure also provides methods of using the engineered DNA ligase polypeptides or compositions thereof in diagnostics and as a molecular biological tool.
    Type: Application
    Filed: January 23, 2024
    Publication date: September 19, 2024
    Inventors: Jacob Hansen Artz, Rachelle Copeland, Jason Fell, Anders Matthew Knight, Mikayla Jianghongxia Krawczyk, Mathew G. Miller, Jovana Nazor, Amani Shoubber, Jonathan Vroom
  • Publication number: 20240209408
    Abstract: The present invention provides engineered 3?O-kinase polypeptides useful for construction of materials used in template-independent polynucleotide synthesis, as well as compositions and methods of utilizing these engineered polypeptides. The present disclosure also describes one-pot methods for conversion of a natural or modified nucleoside to a nucleoside tetraphosphate or NQP.
    Type: Application
    Filed: October 12, 2023
    Publication date: June 27, 2024
    Applicant: Codexis, Inc.
    Inventors: David Entwistle, Stephanie Marie Forgel, Anders Matthew Knight, Mikayla Krawczyk, Philip Provencher, Amani Shoubber, Jonathan Vroom, David Watts, Leland Wong
  • Publication number: 20240209406
    Abstract: The present disclosure provides enzymatic methods for the production of 3?-phosphate-nucleoside-5?-triphosphate (NQP). The present disclosure further provides enzymatic methods for the production of nucleotide-5?-triphosphates.
    Type: Application
    Filed: October 12, 2023
    Publication date: June 27, 2024
    Inventors: David Entwistle, Stephanie Marie Forget, Anders Matthew Knight, Mikayla Jianghongxia Krawczyk, Marissa Greene MacAvoy, Simon Ng, Nicholas Porter, Philip Provencher, Amani Shoubber, Leann Quertinmont Teadt, Jonathan Vroom, David Watts, Leland Ken Wong
  • Publication number: 20240190926
    Abstract: The present invention provides improved P450-BM3 variants with improved activity. In some embodiments, the P450-BM3 variants exhibit improved activity on indanone substrates.
    Type: Application
    Filed: November 21, 2023
    Publication date: June 13, 2024
    Inventors: Margie Tabuga Borra-Garske, Jessica Anna Hurtak, Anders Matthew Knight, Kalyanaraman Krishnamoorthy, Jovana Nazor, James Nicholas Riggins, Nandhitha Subramanian, Jonathan Vroom
  • Publication number: 20240132858
    Abstract: The present invention provides engineered uridine phosphorylase (UP) enzymes, polypeptides having UP activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing UP enzymes are also provided. The present invention further provides compositions comprising the UP enzymes and methods of using the engineered UP enzymes. The present invention finds particular use in the production of pharmaceutical compounds.
    Type: Application
    Filed: January 3, 2024
    Publication date: April 25, 2024
    Inventors: Jonathan Vroom, Jessica Anna Hurtak, Anders Matthew Knight
  • Publication number: 20240108423
    Abstract: A robotic surgical instrument includes an articulation drivable by at least one driving element. Movement of an instrument interface element is transferred to the at least one driving element. A driving element securing member includes at least one tapered side wall and is configured to be coupled to the at least one driving element. A holding member includes an opening configured to receive a fixing member and at least one wall defining a recess having a shape complementary to the shape of the at least one tapered side wall. The fixing member is configured to be received in the opening and apply force to secure the driving element securing member within the recess of the holding member so that the at least one wall of the holding member is in frictional contact with the tapered side wall of the driving element securing member.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 4, 2024
    Applicant: CMR Surgical Limited
    Inventors: Matthew Knight, Pedro Riera Martinez
  • Patent number: 11898174
    Abstract: The present invention provides engineered uridine phosphorylase (UP) enzymes, polypeptides having UP activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing UP enzymes are also provided. The present invention further provides compositions comprising the UP enzymes and methods of using the engineered UP enzymes. The present invention finds particular use in the production of pharmaceutical compounds.
    Type: Grant
    Filed: December 17, 2021
    Date of Patent: February 13, 2024
    Assignee: Codexis, Inc.
    Inventors: Jonathan Vroom, Jessica Anna Hurtak, Anders Matthew Knight
  • Publication number: 20240026319
    Abstract: The present invention relates to plant-produced angiogenins, to related plant cells, plant calli, plants, seeds and other plant parts and products derived therefrom and to uses of plant-produced angiogenins. The present invention also relates to expression of angiogenin genes in plants and to related nucleic acids, constructs and methods.
    Type: Application
    Filed: May 19, 2023
    Publication date: January 25, 2024
    Applicant: Agriculture Victoria Services PTY LTD
    Inventors: German Spangenberg, Aidyn Mouradov, Jianghui Wang, Benjamin Graeme Cocks, Matthew Knight, Matthew McDonagh
  • Patent number: 11847108
    Abstract: A system has data capture devices collecting data from different points in a network. The captured data is written to a data store and is directed to an output. The data from the different data capture devices can be delivered to a data analytics device. As long as the data analytics device is able to keep pace with the data that is directed to the output, that data is used by the analytics device. If the analytics device is not able to keep pace, the data written to the data store is retrieved and is used until the analytics device has caught up.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: December 19, 2023
    Assignee: XILINX, INC.
    Inventors: Steven L. Pope, David J. Riddoch, Matthew Knight
  • Publication number: 20230323767
    Abstract: A method for remotely signalling a downhole assembly comprising one or more downhole tools includes operating a choke arrangement configured to control production fluid flow from a wellbore to produce a first pressure signature in the fluid flow, the first pressure signature defining a trigger signal for the one or more downhole tools of the downhole assembly. The first pressure signature comprises at least a first pressure signal and a second pressure signal in the production fluid flow in the downhole assembly. Operating the choke arrangement to produce a second pressure signature in the production fluid flow in the downhole assembly at a predetermined time period following the first pressure signature, the second pressure signature defining a command signal for initiating operation of a predetermined one or more of the downhole tools of the downhole assembly.
    Type: Application
    Filed: September 14, 2021
    Publication date: October 12, 2023
    Inventors: Euan Murdoch, Matthew Knight, Richard Dalzell
  • Patent number: 11692183
    Abstract: The present invention relates to plant-produced angiogenins, to related plant cells, plant calli, plants, seeds and other plant parts and products derived therefrom and to uses of plant-produced angiogenins. The present invention also relates to expression of angiogenin genes in plants and to related nucleic acids, constructs and methods.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: July 4, 2023
    Assignee: Agriculture Victoria Services PTY LTD
    Inventors: German Spangenberg, Aidyn Mouradov, Jianghui Wang, Benjamin Graeme Cocks, Matthew Knight, Matthew McDonagh
  • Patent number: 11692185
    Abstract: The present invention relates to plant-produced angiogenins, to related plant cells, plant calli, plants, seeds and other plant parts and products derived therefrom and to uses of plant-produced angiogenins. The present invention also relates to expression of angiogenin genes in plants and to related nucleic acids, constructs and methods.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: July 4, 2023
    Assignee: Agriculture Victoria Services PTY LTD
    Inventors: German Spangenberg, Aidyn Mouradov, Jianghui Wang, Benjamin Graeme Cocks, Matthew Knight, Matthew McDonagh
  • Publication number: 20230183663
    Abstract: The present invention provides engineered terminal deoxynucleotidyl transferase (TdT) polypeptides useful in template-independent polynucleotide synthesis using a nucleoside triphosphate-3?-O-removable blocking group (NTP-3?-O-RBG), as well as compositions, methods of utilizing these engineered polypeptides, and polynucleotides encoding the engineered terminal deoxynucleotidyl transferases.
    Type: Application
    Filed: October 13, 2022
    Publication date: June 15, 2023
    Inventors: Charlene Ching, Stephanie Marie Forget, Anders Matthew Knight, Mikayla Jianghongxia Krawczyk, Niusha Mahmoodi, Melissa Ann Mayo, Mathew G. Miller, Jonathan Vroom
  • Publication number: 20230149105
    Abstract: A surgical robot system comprising: a surgical robot, the surgical robot comprising a base, and an arm extending from the base to an attachment for an instrument the arm comprising a plurality of joints whereby the configuration of the arm can be altered; an instrument attached to the arm of the surgical robot; and a control unit configured to receive one or more inputs from an operator of the surgical robot in relation to movement of the instrument and translate the one or more inputs into one or more control signals in accordance with a set of control parameters to control the movement of the instrument, the set of control parameters being one of one or more sets of control parameters associated with the operator.
    Type: Application
    Filed: April 8, 2021
    Publication date: May 18, 2023
    Inventors: Patrick THORNYCROFT, Matthew KNIGHT
  • Patent number: 11576429
    Abstract: There is provided a flavour system for use in a tobacco industry product. The flavour system comprises lyophilised botanical material, an activator capable of releasing flavourant from the lyophilised botanical material through contact of the activator with the lyophilised botanical material, and a removable barrier preventing contact between the lyophilised botanical material and the activator. The barrier is removable to permit the activator to contact the lyophilised botanical material, thereby to cause release of the flavourant.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: February 14, 2023
    Assignee: BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED
    Inventors: Matthew Knight, Ianto Davies, Alex Renouf, Aaron Brookbank, Ignacio Suarez Yanez, Karl Fellbrich
  • Publication number: 20220195400
    Abstract: The present invention provides engineered uridine phosphorylase (UP) enzymes, polypeptides having UP activity, and polynucleotides encoding these enzymes, as well as vectors and host cells comprising these polynucleotides and polypeptides. Methods for producing UP enzymes are also provided. The present invention further provides compositions comprising the UP enzymes and methods of using the engineered UP enzymes. The present invention finds particular use in the production of pharmaceutical compounds.
    Type: Application
    Filed: December 17, 2021
    Publication date: June 23, 2022
    Inventors: Jonathan Vroom, Jessica Anna Hurtak, Anders Matthew Knight